Cite Filings / ORKA / 0001213900-24-072683
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Oruka Therapeutics, Inc. · Filed 2024-08-27 · Acc 0001213900-24-072683

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , ea0212462-8k425_arcabio.htm

Around this filing

  • 2024-09-05 8-K Material agreement · Acquisition or sale completed · Results of operations · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
  • 2024-08-30 4 Options or other derivatives
  • 2024-08-27 425 Prospectus/Communication re Business Combination
  • 2024-08-27 8-K Other events
  • 2024-08-23 8-K Shareholder vote results · Other events
  • 2024-08-20 4 10% owner bought 5,818 shares at an average $2.93 ($17,067)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ea0212462-8k425_arcabio.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…